Clinical Research Directory
Browse clinical research sites, groups, and studies.
Intra-arterial Neuroprotective Strategy for Ischemic STroke Patients With Endovascular Therapy (INSIST-ET)
Sponsor: Hui-Sheng Chen
Summary
To explore the safety and feasibility of intra-arterial neuroprotective strategy in acute ischemic stroke patients who received recanalization operation.
Official title: Intra-arterial Neuroprotective Strategy for Ischemic STroke Patients With Endovascular Therapy (INSIST-ET): One Single Center, Safety and Feasibility Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2020-12-01
Completion Date
2026-05-31
Last Updated
2025-08-21
Healthy Volunteers
No
Interventions
Intra-arterial administration of neuroprotective agents
Intra-arterial administration of 3-n-butylphthalide for 16 to 24 hours during and after the operation at 17.36 to 26.04 ug/min
Locations (1)
Department of Neurology, General Hospital of Northern Theater Command
Shenyang, China